KELLY VISCOSI: Open Payments
NPI 1184732539 · MAYFIELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 43 payments from 10 companies in 2025. Trend: 2023 $816 · 2024 $1,053 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $400 |
| ABBVIE INC. | 13 | $272 |
| Novo Nordisk Inc | 3 | $172 |
| Amgen Inc. | 6 | $132 |
| PFIZER INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Renalytix AI, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, Wegovy, LINZESS, VRAYLAR, OTEZLA, FARXIGA, UBRELVY.
Industry payments across NY — which companies pay providers there.
